Summary: It was shown previously that focal cortical freezing lesions in rats cause widespread decrease in local cerebral glucose utilization (LCGU) in cortical areas of the lesioned hemisphere. This was interpreted as reflecting a depression of cortical activity. It was then demonstrated that cortical serotonin (5-HT) metabolism was increased throughout the lesioned hemisphere of a focally injured brain. To find out if the changes in the serotonergic system are of functional importance and me diate the observed changes in LCG U, the effects of the inhibition of 5-HT synthesis with p-chlorophenylalanine (PCP A) on cerebral metabolism and biogenic amine con tent in injured brain were studied. PCPA in doses up to 300 mg/kg had little, if any, effect on LCG U in intact brain and in doses up to 100 mg/kg did not modify the depressed LCGU in injured brain. In doses of 200 and 300 mg/kg, PCP A selectively increased cortical glucose utilization in the lesioned hemisphere where it was de pressed following injury. PCPA decreased 5-HT levels in U sing focal cortical freezing in the rat as a model of cerebral injury and the deoxyglucose (DG) method as developed and described by Sokoloff et al. (1977) to assess the functional state of trauma tized brain, earlier studies (Pappius, 1981) showed that a widespread, but not uniformly distributed, depression of local cerebral glucose utilization Abbreviations used: DG, deoxyglucose; DHBA, dihydroxy benzylamine; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, sero tonin; LCGU, local cerebral glucose utilization; NE, norepi nephrine; PCPA, p-chlorophenylalanine .
Summary: It was shown previously that focal cortical freezing lesions in rats cause widespread decrease in local cerebral glucose utilization (LCGU) in cortical areas of the lesioned hemisphere. This was interpreted as reflecting a depression of cortical activity. It was then demonstrated that cortical serotonin (5-HT) metabolism was increased throughout the lesioned hemisphere of a focally injured brain. To find out if the changes in the serotonergic system are of functional importance and me diate the observed changes in LCG U, the effects of the inhibition of 5-HT synthesis with p-chlorophenylalanine (PCP A) on cerebral metabolism and biogenic amine con tent in injured brain were studied. PCPA in doses up to 300 mg/kg had little, if any, effect on LCG U in intact brain and in doses up to 100 mg/kg did not modify the depressed LCGU in injured brain. In doses of 200 and 300 mg/kg, PCP A selectively increased cortical glucose utilization in the lesioned hemisphere where it was de pressed following injury. PCPA decreased 5-HT levels in U sing focal cortical freezing in the rat as a model of cerebral injury and the deoxyglucose (DG) method as developed and described by Sokoloff et al. (1977) to assess the functional state of trauma tized brain, earlier studies (Pappius, 1981) showed that a widespread, but not uniformly distributed, depression of local cerebral glucose utilization the cortical and raphe areas of both intact and injured brain in a dose-dependent manner. However, at doses of PCPA ineffective on LCGU (50 and 100 mg/kg), traumati zation still resulted in increased 5-HT metabolism. Doses of PCPA that ameliorated the depression of LCGU in in jured brain completely prevented increases in both 5-HT and its metabolite 5-hydroxyindoleacetic acid seen fol lowing traumatization in untreated animals. These results provide evidence that decreased LCGU in lesioned brain is due to an activation of the serotonergic system by trau matization. The data are in agreement with the postulated inhibitory role of serotonin in the cortex and its involve ment in functional alterations associated with injury. They suggest that blockage of this neurotransmitter system may have a potential in the development of novel therapeutic approaches to brain injury. Key Words: Brain injury-p-Chlorophenylalanine-Local cerebral glucose utilization -Norepinephrine -Serotonin.
(LCGU ) developed with time after lesioning. The effects were not related to the location of the le sion, which was regularly placed in the parietal cortex, but could be made more frontally or cau dally with the same results (Colle et aI., 1986) . The most severe metabolic depression occurred in all the cortical regions of the lesioned hemisphere were 3 days after the lesion LCGU was -50% of normal from frontal to visual cortex (Pappius, 198 1) . Thus, the effect was not restricted to areas surrounding the lesion or overlying the edematous white matter. The metabolic changes were not as sociated with parallel alterations in blood flow, which was slightly elevated throughout the whole brain at the time of the greatest decrease in LCG U. In keeping with the hypothesis that the functional state of cerebral tissue is closely coupled to its me-tabolism (Sokoloff, 198 1) , the demonstrated de pression of cortical glucose utilization was inter preted as a manifestation of widespread cerebral dysfunction resulting from a focal lesion. In other words, the energy needs of cortical areas in injured brain were thought to be diminished because of a functional depression. Such an interpretation is supported by the demonstration in this model of in jury of somatosensory deficits that were signifi cantly correlated with the extent of the depression of glucose utilization in the cortical areas of the le sioned hemisphere (Colle et aL, 1986) .
In search of mechanisms involved in the func tional depression resulting from injury, it was pos tulated that the changes observed in traumatized brain were mediated through a neurotransmitter system or systems (Pappius and Wolfe, 1983a , 1984 , 1986 . Both the serotonergic and noradren ergic systems appeared to be good potential candi dates for such a role. Both innervations are widely distributed to rat cerebral cortex (Beaudet and De scarries, 1976; Descarries et aL, 1977; Levitt and Moore, 1978; Moore and Bloom, 1979; Lidov et aL, 1980; Morrison et aL, 198 1; Parent et aI. , 198 1; Foote et aI. , 1983; Morrison and Magistretti, 1983) , the area most affected in traumatized brain, and both systems have been shown to be altered acutely in association with brain injury (e. g. , Bar eggi et aI. , 1975; Vecht et aI., 1975; Fenske et aI. , 1976; Finklestein et aI. , 1983) . In cerebral cortex serotonin (5-HT) is thought to be an inhibitory transmitter (Bloom et aI. , 1972; Sastry and Phillis, 1977; Taylor and Stone, 198 1) and is envisaged as exerting profound and global influences on cortical function in general (Lido v et aI. , 1980) , possibly not only as a neurotransmitter, but also as a modulator of neuronal activity in a nonsynaptic fashion (Beaudet and Descarries, 1978; Taylor and Stone, 198 1) . Major noradrenergic fibers terminate in all layers throughout the cortex and thus similarly can exert their effects in many regions in a manner not related directly to local activity (Foote et aI. , 1983; Morrison and Magistretti, 1983) .
Subsequent studies showed that 5-HT metabo lism is increased throughout the cortex of the le sioned hemisphere of a focally injured brain, the decrease in 5-HT level being observed only at 24 h but the increase in the metabolite 5-hydroxyindole acetic acid (5-HIA A) content persisting for 6 days post lesion (Pappius and Dadoun, 1987) . 5-HT was not, however, the only transmitter affected by focal brain injury since cortical norepinephrine (NE) content was also decreased, although in contrast to 5-HT, bilaterally. On the other hand, no changes were found in cortical level of dopamine and its me tabolites (Pappius and Dadoun, 1986) .
The present studies were designed to elucidate the functional significance of the changes in 5-HT metabolism in the freezing lesion model of injury by determining the effects of inhibition of 5-HT syn thesis with p-chlorophenylalanine (PCPA ) on the depressed cortical glucose utilization in trauma tized brain.
MATERIALS AND METHODS

General procedure
Small freezing lesions standardized to produce superfi cial focal cortical injury in the rat were made in the left parietal region of halothane-anesthetized male Sprague Dawley rats (300-325 g) by applying a freezing probe (di ameter 4 mm) cooled to -50° for 5 s to the exposed dura. After the lesion was made, the wound was sutured and the animals allowed to awaken. At specified intervals after the lesion, either a [14C]DO study was carried out as described below or the animal was decapitated and the brain processed for analysis of 5-HT, 5-HIAA, and NE according to procedures indicated below. The animals were maintained in a temperature-and light-controlled environment throughout and were always killed at the same time of day (for biogenic amine analysis II :00 a.m. ± 30 min; for LCOU determination between 1:00 and 3:00 p.m.).
PCPA, a known irreversible inhibitor of 5-HT synthesis (Koe and Weissman, 1966; Jequier et aI., 1967) , was given as a single intraperitoneal injection in doses of 50, 100, 200, and 300 mg/kg either 24 h before the lesion was made or at an equivalent time in unlesioned animals. Un treated, unlesioned animals served as normals while un lesioned but appropriately treated animals were the PCPA controls.
The physiological state of the conscious fasted animals destined for LCOU determination was assessed by moni toring arterial blood pressure and rectal temperature and by measurement of the hematocrit, serum glucose, and blood gases prior to the DO study. It was assumed that animals decapitated for biogenic amine analysis were in a similar physiological condition.
The values obtained for the measured variables in 18 normal animals before the start of the DO study were (average ± SE) as follow: mean arterial blood pressure 126 ± 2 mm Hg, rectal temperature 36.2 ± 0.2°C, glu cose 144 ± 5 mg/dl, Pao2 93 ± 2 mm Hg, Pac02 41.0 ± 0.5 mm Hg; pH 7.4 1 ± 0.0 1, hematocrit 50 ± 1%. As previously shown (Pappius, 198 1) , a cortical freezing le sion did not significantly affect any of the above. In the PCPA-treated animals (pooled lesioned and unlesioned), the only significant difference from normal was a fall in Pac02 to 38.3 ± 0.7 mm Hg (n = 18, p < 0.0 1) in the 200-mg group and to 35.3 ± 1. 1 mm Hg (n = 14, p < 0.0l) in the 300-mg group.
Plasma 
Determination of LCGU
In the present experiments, LCGU was measured 3 days after the lesion was made either in untreated an imals or in those given PCPA 24 h before lesioning. This time period was chosen because at that point the depres sion of cortical glucose utilization is most pronounced in untreated lesioned animals. To have appropriate controls, in unlesioned animals PCPA was given 4 days before the LCGU measurement.
LCGU was determined using the 2-deoxy-n-[l4C]glu cose quantitative radioautographic method of Sokoloff et al. (1977) . Briefly, under general anesthesia with 2% halo thane in oxygen and spontaneous respiration, polyeth ylene catheters were placed in the femoral artery and femoral vein. The animals were restrained from the waist down in a loosely applied plaster cast and allowed to re cover from anesthesia for at least 3 h.
After ensuring that physiologic parameters were within normal limits, the LCGU experiment was begun by in jecting a bolus of 30 fLCi of [l4C]DG into the venous cath eter over 30 s (2-deoxy-n-[1-14C]glucose specific activity 50-56 fLCi/mmol; New England Nuclear). Timed arterial sampling for determination of plasma [l4C]DG and glu cose concentrations commenced at the start of injection and was continued for 45 min. The animals were then killed by decapitation and the brain was quickly removed and frozen in Freon XII, cooled at -50 to -60°C in liquid nitrogen vapor. Brains were sectioned in 20-fLm thick slices in a cryostat (American Optical Co., Buffalo, NY, U.S.A.) maintained at -22°C. The dried sections were used to prepare autoradiographs. Calibrated [14C]methyl methacrylate standards (New England Nu clear) were included with each autoradiograph. Densi tometry was performed on the developed autoradio graphs with a Photovolt densitometer (model 52; Photo volt Corp., New York, NY, U.S.A.), using a O.I-mm aperture and averaging the results of at least five readings from each structure studied. Calculation of LCGU was accomplished using a computer program written for a PDP-12 computer (Digital Equipment Corp., Maynard, MA, U.S.A.).
As in previous studies LCGU was measured in 27 structures and areas. However, only representative re sults from noncortical structures are given in Ta bles I and 2 since the effects of PCPA were most pronounced in cortical areas.
Determination of 5-HT, 5-HIAA, and NE content in cerebral cortex and raphe nucleus 5-HT, 5-HIAA, and NE were determined in cerebral cortex tissue and the raphe area in both untreated and PCP A-treated animals on the day of the lesion (day 0) and 1 and 3 days following the freezing lesion, as well as in PCPA-treated controls at corresponding time intervals after PCPA injection.
Cortical tissue samples were hand-dissected at room temperature from the brain quickly removed from the skull following decapitation, as previously described (Pappius and Dadoun, 1987) . The frontoparietal cortex samples (150-200 mg), from which the lesion area was always discarded and the underlying white matter re moved, were rapidly frozen in liquid nitrogen, weighed with care being taken that no thawing occurred, and rap idly homogenized (sonic dismembrator; Artex System Corp., Farmingdale, NY, U.S.A.) in 0.5 ml of ice-cold 0.2 M perchloric acid containing 150 pmol of dihydroxyben zylamine (DHBA) as internal standard. The homogenates were centrifuged at 15,000 rpm at 4°C for 15 min. Super natants were stored at -80°C and thawed just before analysis.
To obtain samples from the raphe area, the cerebellum was removed first and a transverse section made at an angle passing rostrally to the midbrain raphe nuclei, fol lowed by a second cut through the caudal medulla at the level of the obex. Then the raphe area was dissected from the brainstem by two parasagittal cuts I mm lateral from the midline and divided along the midline. Thus, each sample contained serotonergic cell bodies with both as cending and descending projections. The weight of each unilateral sample was always between 20 and 30 mg. The samples were weighed after freezing in liquid nitrogen and extracted in 200 fLl of 0.2 M perchloric acid con taining 150 pmol DHBA as internal standard (Mefford, 1981) .
The chromatography analyses were performed with a high performance liquid chromatograph equipped with a pump (model 590; Waters Associates, Milford, MA, U.S.A.), an automatic injector (WISP 710B; Waters), an integrator (data module 730; Waters), and a model LC-4B (Bioanalytical Systems) glassy carbon (TL3) am perometric detector.
In a procedure adapted from Warnhoff (1984) , a 5-fLm CI8 column RCM 100 (inner diameter 8 mm) protected by a Guard Pak precolumn module (Waters) was used. The mobile phase, consisting of 0. 1 M sodium acetate, 0.1 M citric acid, 15% (vol/vol) methanol, and 500 fLlIL N-dibu tylamine (pH 3.5), was pumped at flow rate of 0.6 mllmin. The detector potential was set at 0.70 V vs. Ag/AgCI ref erence electrode. The standard stock solution contained 100 fLg/ml H20 of the following: 5-hydroxytryptamine hy drochloride, 5-hydroxyindoleacetic acid hydrochloride, and DHBA (internal standard), all from Sigma Chemical Co. (St. Louis, MO, U.S.A.). The stock solution was stored at -80°C. Aliquots were thawed and diluted to I: 1 ,000 daily.
This procedure gave excellent resolution of the 5-HT, 5-HIAA, and DHBA peaks in all samples and of NE in supernatants from raphe nucleus. For determination of NE in cerebral cortex, the run was repeated with a modi fied mobile phase (5% methanol, 350 fLl N-dibutylaminel L) to allow better separation of the NE peak from the solvent front peak.
Correlation between cortical glucose utilization and 5-HT content of raphe nucleus in lesioned brain
In 10 animals given different doses (50-300 mg/kg) of PCPA 24 h before the lesion was made, a DG study was performed on the third postlesion day and determination of glucose utilization was made autoradiographically in cortex regions after removal of brainstem areas. Raphe area was dissected out as described above and extracted for determination of 5-HT, 5-HIAA, and NE.
LCGU results in the lesioned hemisphere for five cor-tical areas in each animal (visual, auditory, parietal, sen sorimotor, and frontal) were expressed as percentage of normal and averaged to give cortical glucose utilization in Fig. 2 .
Statistical analysis
The Bonferroni procedure (two tailed) for simulta neous multiple comparisons was used for determination of statistical significance between groups (Wallenstein et aI., 1980) .
In Ta ble 1 PCPA-treated groups were compared with normal; in Ta ble 2 lesioned treated groups were com pared with both the normal and the lesioned untreated groups. In Ta bles 3, 4, and 5 intact treated groups and the lesioned untreated group were compared with the normal group, while lesioned treated groups were compared only with the corresponding PCPA controls.
RESULTS
Effect of PCP A on LCGU in unlesioned brain
PCPA in doses of 100, 200, and 300 mg given 4 days earlier had little, if any effect, on LCGU in unlesioned animals, the slight decrease in cortical areas reaching significance in only two regions with the 200-mg/kg dose ( Table I) .
Effect of PCP A on LCGU in lesioned brain
As shown previously (Pappius, 1981) , 3 days fol lowing a focal freezing lesion, LCGU was severely depressed in all cortical areas of the lesioned hemi sphere and to a much lesser extent in some, but not all, subcortical structures (Table 2) . Some decrease in LCGU was also seen in the cortical and subcor tical areas of the hemisphere contralateral to the le sion. Brainstem structures and white matter regions were unaffected.
PCPA in doses of 50 and 100 mg/kg given 24 h before the lesion was made had no effect on cortical glucose utilization throughout the lesioned brain. In marked contrast, PCPA in doses of 200 and 300 mg/kg selectively increased glucose utilization in all cortical areas of the lesioned hemsiphere, whereas in untreated animals it was depressed following in jury. However, normal levels were not reached. The two doses were equally effective in elevating the cortical LCGU on the side of the lesion. There was also some effect of the two higher doses of PCPA in subcortical areas of the lesioned hemi sphere, but with one exception (substantia nigra) not in the contralateral hemisphere.
Effect of PCPA on 5-HT and 5-HIAA content of cerebral cortex in intact and lesioned brain
In intact brain 24 h after an intraperitoneal injec tion of PCPA (day 0), there was a dose-dependent decrease in cortical content of 5-HT and 5-HIAA (Table 3) . Following 100-, 200-, and 300-mg injec tions, there was further depletion up to day 3. Sim ilar results were obtained in the hemisphere contra lateral to the lesion in the traumatized brain. As previously reported (Pappius and Dadoun, 1987) , in the lesioned hemisphere of untreated an imals, there was a significant decrease in 5-HT con tent of the cortex on postlesion day 1 and a highly significant increase in 5-HIAA on both days 1 and 3, indicative of an increased turnover in the seroto nergic system. In animals pretreated with 50 and 100 mg PCPA/kg, doses without effect on glucose utilization (see above), no decrease in 5-HT content due to the lesion was demonstrated, but 5-HIAA was significantly increased on both days 1 and 3 as compared with PCPA controls. These results indi- Vol, 8, No, 3, 1988 cate that injury still induced an increase in 5-HT turnover despite lowering by these doses of the drug of the absolute levels of both the neurotrans mitter and its metabolite.
In contrast, in animals pretreated with 200 and 300 mg PCPA/kg, doses that, as indicated above, significantly ameliorated the metabolic depression in traumatized brain, no changes in cortical 5-HT and 5-HIAA levels were demonstrated when com pared with corresponding PCPA controls, with both indoleamines depleted to < 10% of normal cortical levels. PCPA was given as a single dose 24 h before day 0, thus 24 h before lesion in traumatized animals. Values are means ± SE, with no. of animals in parentheses.
a Significantly different from normal, p < 0.0 I.
b Significantly different from corresponding PCPA control, p < 0.0 1.
, Significantly different from corresponding PCPA control, p < 0.05.
Effect of PCPA on S-HT and S-HIAA content of raphe area in intact and lesioned brain
The effect of a freezing lesion on the content of 5-HT and 5-HIAA in the raphe area was not deter mined previously. Data summarized in Ta ble 4 show a general tendency of both 5-HT and 5-HIAA to increase bilaterally in the raphe with time after a unilateral freezing lesion in untreated animals and those pretreated with 50 and 100 mg PCPA/kg, but not in the 200-and 300-mg PCPA/kg groups. How ever, because of considerable variability in the re sults, the differences from appropriate controls, when they occurred, were not always statistically significant.
On the other hand, when the results were ex pressed as a sum of the neurotransmitter and its metabolite (5-HT + 5-HIAA), as in Fig. 1 , highly statistically significant increases indicative of acti vated 5-HT metabolism in the raphe area were demonstrated on postlesion day 1 and, and to a lesser extent, on day 3 in lesioned animals, un treated or pretreated with 50 or 100 mg PCPA/kg. In contrast to findings in the cortex where such changes were restricted to the lesioned hemisphere, in the raphe unequivocally bilateral effects were in duced by the injury. As in the cortex, at doses of PCPA that ameliorated the depression in glucose utilization in the lesioned hemisphere (200 and 300 mg/kg), no effect of injury on 5-HT metabolism in the raphe area was noted, although neither 5-HT nor 5-HIAA was as depleted as in the cortex.
Effect of PCP A on NE content of cerebral cortex and raphe nucleus in intact and lesioned brain
It will be seen from Ta ble 5 that in traumatized brain, bilateral decreases in cortical NE level were confirmed (Pappius and Dadoun, 1986) . PCPA tended to decrease transiently the NE content of intact brain, with the effect being statistically sig nificant only at the higher doses of PCPA on day 1. In PCPA-treated animals the effect of injury on cor tical NE was statistically significant only in the le sioned hemsiphere at 300 mg/kg on day 3. How ever, when the PCPA-treated groups were pooled, the differences in NE levels between control and lesioned brain were statistically significant (control: n = 21, NE 1,636 ± 63 pmol/g; day 3 lesioned hemisphere; n = 20, NE 1,314 ± 40 pmol/g, p < 0. 01; hemisphere contralateral to lesion: NE 1,468 ± 30 pmol/g, p < 0. 05). The NE content of the raphe area was unaffected by injury or PCPA.
Correlation between cortical glucose utilization and S-HT content of raphe nucleus in traumatized brain
In Fig. 2 cortical glucose utilization on the side of the lesion was plotted against 5-HT content of the raphe area in the lesioned hemisphere of the same animals. A highly statistically significant correla tion was found (r = 0.82, p < 0. 0 1). A similar cor relation was noted with 5-HT content in the contra lateral raphe area (r = 0.76, p < 0.01). Cortical 5-HT content could not be determined in these an- (7) 2,270 ± 109 (5)" 3,321 ± 190 (7) 2.271 120 (7) 1,383 ± 180 (5)"
2,194 ± 125 (7) 100 mg/kg 2.020 202 (6)" 1,280 ± 108 (7)" 1.340 ± 187 (5)" 1,262 139 (6)"
1,720 ± 229 (6)
PCPA was given as a single dose 24 h before day 0, thus 24 h before lesion in traumatized animals. Values are means ± SE, with no. of animals in parentheses.
" Significantly different from normal, p < 0.01. imals since the tissue was used for autoradiog raphy. In other PCPA-treated animals, parallel dose-dependent changes in 5-HT content of the raphe area and the frontoparietal cortical regions were found (Tables 3 and 4) .
DISCUSSION
The major conclusion from the results summa rized in this article is that the depressed functional state of a lesioned brain, as assessed by metabolic mapping with the DG method, can be ameliorated by inhibition of 5-HT synthesis. These findings provide compelling evidence that the increased turnover of 5-HT throughout the cortex of focally lesioned hemisphere is of functional significance. This implies that alterations in the levels of indole amines in injured brain do reflect increased release of this transmitter. Such a conclusion is compatible with the postulated inhibitory nature of 5-HT action on cortical neuronal activity (Bloom et aI., 1972; Sastry and Phillis, 1977; Ta ylor and Stone, 1981) .
It is unlikely that blood elements were the source of the increased 5-HT turnover found in the cortical areas of injured brain. Release of 5-HT from platelets in the lesion area has been demonstrated 6 h after lesioning in the cat (Costa et aI., 1974) . However, rat platelets contain little 5-HT (Costa et aI., 1974) , and the lesion area was always excluded from the tissues analyzed in the present experi-
ments, Persistence of the increased 5-HT metabo lism for 6 days after injury is a further argument against it being of blood origin. Similarly, the in crease in release of 5-HT in injured brain cannot be attributed to stress (Joseph and Kennett, 1983) as there was no physiological evidence (e.g., in creased blood pressure or elevated serum glucose levels) that the animals were chronically stressed and such effects would be expected to occur bilat erally.
It might have been anticipated that in intact an imals decreased 5-HT synthesis would lead to in creased glucose utilization, particularly in the cortex, where this neurotransmitter is thought to be inhibitory. This was not the case in PCPA-treated unlesioned animals where with the higher doses of the drug, if anything, lower rates of LCGU were found. Such negative results with the DG method must be interpreted with caution since they pre sumably reflect the overall functional state of the brain rather than the lack of involvement of a spe cific pathway (McCulloch et aI., 1982) . Under normal conditions changes in one neuronal system may be counterbalanced by those in another, and in the case of 5-HT complex reciprocal interrelation ships with other neurotransmitters have been well documented (Soubrie et aI., 1984; Vanderwolf and Baker, 1986) . Furthermore, in the cortex the exact function of 5-HT remains to be elucidated (Emson and Hunt, 1979; Soubrie et aI., 1984; Jones, 1986) , Table 4 . "Statistically significantly different from control, p < 0.01; 'statistically significantly different from control, p < 0.05.
but like that of NE (Cedarbaum and Aghajanian, 1978; Waterhouse and Woodward, 1980; Aston Jones, 1985) it appears to involve the modulation of the activity of other transmitters, at least to some degree. Under essentially resting conditions, it may be necessary to challenge the overall system before general functional effects can be demonstrated. Brain injury may be one such situation where acti vation of the serotonergic system by trauma results in functional alterations in the cortex that can then be selectively affected by inhibition of 5-HT syn thesis. It is also possible that with finer resolution than was available in the present studies, alter ations in glucose utilization of discrete structures such as the raphe nuclei could be demonstrated in intact PCPA-treated animals. The lack of effect of the lower doses of PCPA in the freezing lesion model of injury is in agreement with electrophysiological data showing that under normal conditions the amount of 5-HT synthesized is in excess of what is needed to meet functional requirements and that brain 5-HT must fall to ex tremely low levels before function is impaired (Vanderwolf and Baker, 1986) . With doses of PCPA of 50 or 100 mg/kg in lesioned brain, apparently enough 5-HT can still be mobilized (Fig. 1) to main tain the functional depression associated with injury. Only when the increase in 5-HT turnover as a result of injury is completely prevented at doses of PCPA exceeding 200 mg/kg is the functional de pression affected. Thus, despite highly significant correlation between the cortical glucose utilization and the 5-HT content of the raphe area (Fig. 2) and by inference of the cortex, since the two change in parallel under these conditions, the capacity for in creased turnover is probably more important than the 5-HT level per se in determining the effective ness of PCPA doses in injured brain.
The pathologically induced increase in 5-HT turnover was shown in the present studies to be the cause of depressed LCGU. A similar effect was demonstrated as a result of pharmacologically raised 5-HT levels. Thus, intracarotid administra tion of 5-HT in the presence of monoamine oxidase inhibition has been shown to acutely decrease cor tical LCGU (Grome and Harper, 1985) . In contrast, there is a recent report that electrical stimulation of the raphe increased glucose use in a number of tha lamic structures and in highly circumscribed frontal regions of the cortex (Cudennec et ai., 1987) . Monoamine oxidase inhibition followed by 5-HT has also been shown to decrease cerebral blood flow (Eidelman et ai., 1978) . This, however, was not the case in lesioned brain in which uncoupling of LCGU and local cerebral blood flow was clearly demonstrated (Pappius, 198 1) . The mechanisms re sponsible for the uncoupling of cerebral metabolism and blood flow in injured brain, confirmed recently by Gaab et al. (1987) , are unknown. Whether cere bral vessels are less responsive to 5-HT under these conditions or whether the relative vasodilatation is due to other factors remains to be elucidated. The effects of PCPA in the freezing lesion model of brain injury do not appear to be mediated by changes in NE. Biochemical and functional interac tions between the noradrenergic locus ceruleus and serotonergic raphe systems are well documented (e.g., Kostowski et aI., 1974; Saavedra et aI., 1976; Pujol, 1979; Pujol et aI., 198 1; Agren et aI., 1986; Brassard et aI., 1987) and both systems are affected by brain injury (Pappius and Dadoun, 1986, 1987) . PCPA has been reported to affect NE levels in brain under some conditions (Miller et aI., 1970; Rebec et aI., 1981; Reader and Gauthier, 1984; Reader et aI., 1986; Vanderwolf and Baker, 1986) ; in all cases, however, following higher doses than used in the present experiments. The decrease in cortical NE resulting from traumatization was statistically sig nificant when pooled groups were compared with pooled controls. Thus, PCPA did not prevent the alteration of NE content resulting from injury .
The pathways involved in inducing changes in the serotonergic system in injured brain remain ob scure, but are most likely polysynaptic. In the cat, the nucleus raphe dorsalis has been shown to re ceive afferent projections from the locus ceruleus complex and several other areas (Sakai et aI., 1977) , but to date no direct projections from cor tical areas have been demonstrated. Widespread ascending projections from the midbrain raphe to all cortical areas are well documented (Beaudet and Descarries, 1976; Moore et aI., 1978; Lidov et aI., 1980; Parent et aI., 198 1) and have been reported to project unilaterally (either ipsilaterally or £ontralat erally) from the dorsal raphe (van der Kooy and Hattori, 1980) and bilaterally or contralaterally from the median raphe (Jacobs et aI., 1978) . In view of these findings, unilateral effects of a focal cor tical injury on the serotonergic system in the cortex with bilateral changes in the raphe area are particu larly difficult to explain in terms of known anatom ical connections. In keeping with our working hy pothesis (Pappius and Wolfe, 1983a , 1984 , 1986 , other mechanisms are most likely involved in the overall response of the brain to injury mediated by a variety of other processes such as the arachidonic acid cascade and possibly also other transmitter systems. Recently evidence has been obtained that prostaglandin D2, the major eicosanoid in the rat, functions as a modulator of serotonergic activity in this species (Bhattacharya et aI., 1985) , while pros taglandin formation has also been implicated as one of the underlying mechanisms in the widespread depression in the functional state of the rat brain that develops in response to a freezing lesion (Pappius and Wolfe, 1983b) .
Finally, the release of NE has been considered as protective for brain recovery from ischemia by some (Koide et al., 1986) and as deleterious by others (Busto et aI., 1985) . The present findings that inhibition of 5-HT synthesis in traumatized brain leads to normalization of cortical function, as determined by metabolic mapping, suggests that blockage of this neurotransmitter system may have a potential in the development of novel therapeutic approaches to brain injury and perhaps other con ditions associated with depressed cerebral func tion, such as stroke.
